DNA|Analyst Targets
DNA|Company Info
DNA|Insider Trading
DNA|Fundamentals
DNA|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $-0.54 | - | - |
| Q1'26 | $-1.09 | $-1.28 | -17.3% |
| Q3'25 | $-1.24 | $-1.45 | -16.9% |
| Q2'25 | $-1.57 | $-1.10 | +29.8% |
| Q1'25 | $-1.77 | $-1.68 | +5.1% |
| Q4'24 | $-1.30 | $-1.21 | +6.7% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $22M | - | - |
| Q1'26 | $42M | $19M | -53.6% |
| Q3'25 | - | $39M | - |
| Q2'25 | - | $50M | - |
| Q1'25 | - | $48M | - |
| Q4'24 | - | $44M | - |
DNA|Monthly Returns
Market Data
DNA Stock Snapshot
- Market cap
- 0.78B
- Day range
- $10.40 – $11.80
- News sentiment
- 55/100 · Neutral
- Analyst target
- $8.00 (-32.0%)
- Consensus
- Sell · 12 analysts
Price action on DNA is defensive - rallies are being sold rather than extended. Company-specific news dominates here; sector-level flows matter less than for larger names.
Behaviour On Record
What DNA's own history says about today's numbers
- Realized volatility (21d)
- 155.9% 99th pct
- Below its peak
- -98.0%
- vs 200-day average
- +39.0%
- Up days (1y)
- 49%
Ginkgo Bioworks Holdings Inc. is currently running 155.9% annualised volatility over the last 21 sessions. Measured against DNA's own 5 years of daily returns rather than a market-wide average, that is the 99th percentile — an extreme by its own standards, against a typical reading of 91.5%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
DNA is trading -98.0% below its running peak. Across 4 full years on file, its median worst-drawdown-in-a-year was -74.7%, and the deepest was -91.9% in 2024. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.
Price sits +39.0% from its 200-day moving average. Against every other day in its history, that gap ranks at the 97th percentile — a wider gap than this stock usually carries. Over the past year DNA closed higher on 49% of sessions, and it is currently 1 session into a rising streak.
On October specifically: over 6 years of records, DNA finished the month higher 1 of 6 times, with a median return of -8.4% and an average of -4.9%. Its strongest month historically has been September at +25.6% on average, its weakest February at -23.0%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: DNA has opened more than 2% away from the prior close in 360 of 1,380 sessions (26.1% of the time), with the largest gaps running +15.4% and -9.0%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
All figures computed from 1,381 daily closes between 2021-04-19 and 2026-10-15, split-adjusted, recomputed daily. Percentiles are against DNA's own 6-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of DNA's sector?
Ginkgo Bioworks Holdings Inc. sits in the Health Care sector, currently ranked 1st of 12 GICS sectors by relative-strength rotation score (leading). Within its narrower Biotechnology industry group, DNA ranks 9th of 15 tracked industries, improving.
- Sector rank
- #1 of 12
- Sector state
- Leading
- Sector rotation score
- 100
- Industry rank
- #9 of 15
Analyst Rating Changes
Are analysts turning bullish or bearish on DNA?
TD Cowen most recently reiterated its rating on Ginkgo Bioworks Holdings Inc. to Hold on Oct 13, 2026 with a price target of $11 (from $9). Over the last 90 days, coverage has run 0 upgrades against 1 downgrade, a net bearish lean.
- Latest action
- TD Cowen — Hold
- 90-day upgrades
- 0
- 90-day downgrades
- 1
- Net rating momentum
- -1
Peers & ETF holders
DNA peers & ETF holders
BiotechnologyMarket cap · today
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | ▲ Buy | 4,282,903 | 6.66% | $42.44M | 2026-08-07 |
| Viking Global Investors LP | • Hold | 3,577,128 | 5.57% | $35.45M | 2026-08-14 |
| Vanguard Group Inc | ▲ Buy | 2,900,952 | 4.51% | $24.11M | 2026-01-29 |
| Baillie Gifford & Co | • Hold | 2,391,649 | 3.72% | $23.70M | 2026-08-06 |
| Anchorage Capital Group, L.L.C. | • Hold | 1,746,363 | 2.72% | $17.31M | 2026-08-14 |
| Geode Capital Management, LLC | ▲ Buy | 1,222,016 | 1.90% | $12.11M | 2026-08-12 |
| Millennium Management LLC | ▲ Buy | 638,676 | 0.99% | $6.33M | 2026-08-14 |
| AQR Capital Management LLC | ▲ Buy | 621,625 | 0.97% | $6.16M | 2026-08-14 |
| Goldman Sachs Group Inc | ▼ Sell | 607,376 | 0.94% | $6.02M | 2026-08-14 |
| Bank of America Corp | ▲ Buy | 545,852 | 0.85% | $5.41M | 2026-08-14 |
| Renaissance Technologies LLC | ▲ Buy | 539,856 | 0.84% | $5.35M | 2026-08-13 |
| Northern Trust Corp | ▲ Buy | 405,141 | 0.63% | $4.01M | 2026-08-13 |
| Invesco Ltd. | ▼ Sell | 211,723 | 0.33% | $2.10M | 2026-08-14 |
| Caxton Associates LLP | ▲ Buy | 154,647 | 0.24% | $1.53M | 2026-08-14 |
| D. E. Shaw & Co., Inc. | ▲ Buy | 151,356 | 0.24% | $1.50M | 2026-08-14 |
| Morgan Stanley | ▼ Sell | 144,314 | 0.22% | $1.43M | 2026-08-13 |
| JPMorgan Chase & Co | ▲ Buy | 134,040 | 0.21% | $1.37M | 2026-08-12 |
| Citadel Advisors LLC | ▲ Buy | 130,935 | 0.20% | $1.30M | 2026-09-02 |
| Marshall Wace, LLP | ▼ Sell | 77,937 | 0.12% | $772.4K | 2026-08-13 |
| Allstate Corp | ▲ Buy | 70,455 | 0.11% | $698.2K | 2026-08-13 |
| Two Sigma Investments, LP | ▼ Sell | 60,454 | 0.09% | $599.1K | 2026-08-14 |
| Citigroup Inc | ▲ Buy | 45,826 | 0.07% | $454.1K | 2026-08-03 |
| Wells Fargo & Company | ▲ Buy | 41,908 | 0.07% | $415.3K | 2026-08-14 |
| Susquehanna International Group, LLP | ▼ Sell | 39,372 | 0.06% | $390.2K | 2026-08-14 |
| AllianceBernstein L.P. | ▲ Buy | 55,792 | 0.09% | $342.0K | 2026-08-14 |